Table 3. Details of characteristics and therapeutic outcomes of enrolled patients.
Patient | Age | Sex | Tumor location | Tumor diameter, mm | Macroscopic type | Procedure time, min | En bloc/R0 resection | Approach | Adverse events |
1 | 78 | M | Pyriform sinus (Lt) | 20 | IIb | 63 | Yes/Yes | Both | None |
2 | 62 | F | Pyriform sinus (Rt) | 17 | IIb | 27 | Yes/Yes | Both | None |
3 | 62 | F | Pyriform sinus (Rt) | 9 | IIb | 15 | Yes/Yes | Oral | None |
4 | 63 | M | Epiglottic vallecula | 7 | IIb | 50 | Yes/Yes | Both | None |
5 | 68 | M | Posterior hypopharyngeal wall | 7 | IIc | 12 | Yes/Yes | Both | None |
6 | 71 | M | Pyriform sinus (Lt) | 10 | IIa | 13 | Yes/Yes | Oral | None |
7 | 83 | M | Pyriform sinus (Rt) | 50 | IIb | 112 | Yes/No | Oral | None |
8 | 69 | F | Posterior oropharyngeal wall | 30 | IIb | 45 | Yes/Yes | Oral | None |
9 | 70 | M | Pyriform sinus (Rt) | 32 | IIc | 32 | Yes/No | Oral | None |
10 | 67 | M | Posterior hypopharyngeal wall | 10 | IIb | 23 | Yes/Yes | Oral | None |
11 | 70 | M | Pyriform sinus (Lt) | 25 | IIb | 73 | Yes/Yes | Oral | None |
12 | 73 | M | Pyriform sinus (Lt) | 17 | IIc | 18 | Yes/Yes | Oral | None |
13 | 73 | M | Pyriform sinus (Rt) | 8 | IIb | 11 | Yes/Yes | Oral | None |
14 | 73 | M | Pyriform sinus (Rt) | 15 | IIb | 15 | Yes/Yes | Oral | None |
15 | 73 | M | Pyriform sinus (Lt) | 15 | IIc | 43 | Yes/Yes | Both | None |
16 | 66 | M | Pyriform sinus (Rt) | 18 | IIb | 30 | Yes/Yes | Oral | None |
17 | 68 | M | Pyriform sinus (Rt) | 33 | IIb | 93 | Yes/No | Both | None |
18 | 76 | F | Pyriform sinus (Lt) | 10 | IIb | 21 | Yes/Yes | Oral | None |
19 | 64 | M | Pyriform sinus (Lt) | 28 | IIb | 40 | Yes/Yes | Both | None |
20 | 63 | F | Posterior cricoid area | 25 | IIa | 20 | Yes/Yes | Oral | None |
En bloc resection was defined as resection of the entire tumor in a single piece. R0 resection was defined as complete resection with histologically negative lateral and vertical margins.